Previous Next
Atypical hemolytic uremic syndrome is a thrombotic microangiopathy, caused by uncontrolled activation of the alternative complement pathway in the context of autoantibodies or rare pathogenic genetic variants in complement proteins. Such a syndrome can occur during pregnancy, with serious or even fatal consequences. Diagnosis remains difficult due to clinical signs similar to other pregnancy complications, in particular hypertensive disorders. In this narrative review, researchers describe two cases of atypical hemolytic uremic syndrome in pregnant women to illustrate the diagnostic and therapeutic challenges. The first case involved a 30-year-old woman who developed the syndrome in the first trimester of pregnancy, and the second case involved a 22-year-old woman who developed severe postpartum HELLP syndrome.

Source(s) :
Michael Che et al. A Case-Based Narrative Review of Pregnancy-Associated Atypical Hemolytic Uremic Syndrome/Complement-Mediated Thrombotic Microangiopathy. Kidney Int. 2024 Feb 24:S0085-2538(24)00158-3. ;

Last press reviews


SARS-CoV-2: What are its impacts on male fertility?

Since its emergence in 2019, SARS-CoV-2 has disrupted global public health...

Adherence to Antiretroviral Therapy (ART): The role of digital health in supporting HIV-positive patients

Adherence to antiretroviral therapy (ART) is essential to prevent the prog...

Stress and its impacts on brain alterations: toward a better understanding of ADHD

Attention-Deficit / Hyperactivity Disorder (ADHD) is a complex neurodevelo...